Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more ➡
Download
Standard view
Full view
of .
Add note
Save to My Library
Sync to mobile
Look up keyword
Like this
6Activity
×
0 of .
Results for:
No results containing your search query
P. 1
Pfizer R&D Pipeline as of February 2008

Pfizer R&D Pipeline as of February 2008

Ratings:

4.0

(1)
|Views: 4,003|Likes:
Published by jennabush

More info:

Published by: jennabush on Jul 01, 2008
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See More
See less

04/06/2013

pdf

text

original

 
 
Copyright © 2008 Pfizer, Inc. All rights reserved.
Pfizer
Pipeline
 
as of February 28, 2008
As some programs are still confidential, somecandidates may not be identified in this list. Inthese materials, Pfizer discloses Mechanism ofAction (MOA) information for candidates fromPhase 3 through regulatory approval. With a viewto expanding the transparency of our pipeline,commencing with this update, Pfizer now isincluding new indications or enhancements whichtarget unmet medical need or represent significantcommercial opportunities. The informationcontained on these pages is correct as ofFebruary 28, 2008.VisitPfizer.com/pipeline,Pfizer’s online databasewhere you can learn more about our portfolio of newmedicines and find out more about our Researchand Development efforts around the world.
 
 
Pfizer Pipeline – as of February 28, 2008
The information provided on this page is for general information only and is subject to the Terms of Use. It is notintended to provide medical advice or guidance, and should not be used for that purpose. Medical use of anyproduct should be strictly in accordance with the approved prescribing information. Copyright © 2008 Pfizer Inc.All rights reserved. Page
2
of
20
 
Table of Contents
Pfizer Pipeline Snapshot...................................................................................................3
 
Pfizer Pipeline.....................................................................................................................4
Phase 1............................................................................................................................4
Phase 2............................................................................................................................5
Phase 3............................................................................................................................6
Registration......................................................................................................................6
Recent Approvals.............................................................................................................6
Projects Discontinued from Development........................................................................7
Phases of Development.....................................................................................................8
The Phases of Clinical Development...............................................................................8
Phases of Development (continued)................................................................................9
Registration......................................................................................................................9
Recent Approvals.............................................................................................................9
Phase 4............................................................................................................................9
Product Pipeline Therapeutic Areas and Conditions....................................................10
Allergy & Respiratory.....................................................................................................10
 
Cardiovascular, Metabolic and Endocrine Diseases (CVMED)......................................11
 
Gastrointestinal & Hepatology........................................................................................12
Genitourinary/Sexual Health..........................................................................................13
Infectious Diseases........................................................................................................14
Inflammation..................................................................................................................15
Neuroscience.................................................................................................................16
Oncology........................................................................................................................18
Ophthalmology...............................................................................................................19
Pain................................................................................................................................19
 
 
Pfizer Pipeline – as of February 28, 2008
The information provided on this page is for general information only and is subject to the Terms of Use. It is notintended to provide medical advice or guidance, and should not be used for that purpose. Medical use of anyproduct should be strictly in accordance with the approved prescribing information. Copyright © 2008 Pfizer Inc.All rights reserved.Page
3
of
20
 
Pfizer Pipeline Snapshot

Activity (6)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
Steven Brunnert liked this
ranachaman liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->